Shetzline Michael
SVP, CMO, Head-Res&Drug
Shetzline Michael has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 12, 2026.
On the most recent filing, Shetzline Michael is listed as SVP, CMO, Head-Res&Drug at IRONWOOD PHARMACEUTICALS INC. Inside the rolling window, Shetzline Michael reported no open-market purchases and 2 open-market sales totaling $122K in IRWD. The largest disclosed transaction in the window is a sale of 17,012 IRWD shares on Feb 24, 2026, worth $62K.
Companies traded
Other insiders at IRWD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$122K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Shetzline Michael made?
Shetzline Michael has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Shetzline Michael trade?
Shetzline Michael has filed SEC Form 4 disclosures for 1 company, including IRWD.
When was Shetzline Michael's most recent SEC Form 4 filing?
Shetzline Michael's most recent SEC Form 4 filing on Tracefour is dated Mar 12, 2026.
What is Shetzline Michael's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Shetzline Michael is listed as SVP, CMO, Head-Res&Drug.
What is Shetzline Michael's total buy and sell value in the current window?
Inside the rolling retention window, Shetzline Michael bought $0 and sold $122K based on SEC Form 4 filings.
What was Shetzline Michael's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 17,012 IRWD shares on 2026-02-24, worth $62K, per SEC Form 4 filings.